Evommune Inc EVMN

$7.21 -0.42 (-5.50%)

Valuation

Market cap
276,908,000
Revenue TTM
$13,000,000
Net income TTM
$-68,870,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-529.77%
Debt to equity
0.00

Trading

Volume
262,302
Avg volume
947,042
Day's range
$7.14 – $7.77
Shares out
36,292,000
Stochastic %K
58%
Beta
—
Analysts
Moderate Buy
Price target
$22.00

Price

Company profile

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The compan...

Show more

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is headquartered in Palo Alto, California.

Industry
Biotechnology
Sector
Healthcare
Phone
(925) 247-4481
Website
https://www.evommune.com
Address
1891 Page Mill Road, Palo Alto, United States

Latest news

Stocktwits

LewisDaKat Nov 9, 3:30 PM
$EVMN Evommune to Present at Upcoming Investor Conferences https://marketwirenews.com/stock/evmn/news/evommune-to-present-at-upcoming-investor-conferences-5557592132975119.html?utm_source=stocktwits
0 replies
24DV4NC3D Nov 6, 8:45 PM
$EVMN ⚡️WHAT DID I SAY?!⚡️ DONT💤 … ...💥🧨💥 >>>> >>>>> 🎯🎯🎯…. 🚀 >> GREAT SETUP << >>>>>>> LISTEN! <<<<<<<<
0 replies
OpenOutcrier Nov 5, 1:27 PM
$EVMN (+9.3% pre) Evommune Announces Webcast Discussing EVO570 and Its Expanding Immunology Portfolio Today at 8:30 a.m. ET https://ooc.bz/l/120024
0 replies
GTA_Terminal Nov 5, 10:09 AM
Off-exchange trading in $EVMN ran below normal, about 0.1x its usual pace. Big money was quieter than usual off the exchanges; the full read has the levels and the institutional holders. Look up any stock's options flow and dark pools on the GTA Terminal, free for 14 days: https://globaltradersacademy.com/?utm_source=stocktwits&utm_medium=social&utm_campaign=trial&utm_content=EVMN Read the full article for the full details: https://globaltradersacademy.com/articles/dark-pool-check-evommune-evmn?utm_source=stocktwits&utm_medium=social
0 replies
flychicken1991 Nov 5, 8:59 AM
$EVMN Evommune Announces $30 Million Private Placement - BioSpace. Impact: Negative (74%). Issuing 4,966,889 common shares reduces existing holders' ownership percentage and introduces a $6.04 financing-price reference that could pressure EVMN's valuation over the next few trading sessions... Source and what to watch next: https://nimpact.tech/newsimpact/news/146ee4ee6b8c58fb/evmn-evommune-announces-30-million-private-placement-biospace?utm_source=stocktwits&utm_medium=story_url
0 replies
flychicken1991 Nov 4, 10:58 PM
$EVMN For $20M upfront and warrants, Evommune (EVMN) licenses EVO570 with milestone payments possible. - Stock Titan. Impact: Negative (76%). Issuing 4,966,889 placement shares would dilute existing EVMN holders, while the $20 million licensing payment consumes much of the planned $30 million gross raise. Hinova's warrants add potential dilution or an additional cash claim... Source and what to watch next: https://nimpact.tech/newsimpact/news/3e97ade1291d6d30/evmn-for-20m-upfront-and-warrants-evommune-evmn-licenses-evo570-with-mil?utm_source=stocktwits&utm_medium=story_url
0 replies
ChampionEntries Nov 4, 10:13 PM
$EVMN Evommune Announces $30 Million Private Placement
0 replies
topstockalerts Oct 28, 5:31 PM
Top Gainers PT2 $GMAB $AXGN $POM $EVMN $PODC
0 replies